The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target
Abstract
Nuclear factor kappa B (NF‐κB) is an ubiquitous rapid response transcription factor in cells involved in immune and inflammatory reactions, and exerts its effect by expressing cytokines, chemokines, cell adhesion molecules, growth factors, and immunoreceptors. In this manner, NF‐κB contributes to immunologically mediated diseases such as allograft rejection, rheumatoid arthritis, and bronchial asthma. The prototypic inducible form of NF‐κB is a heterodimer composed of NF‐kB1 and RelA, which both belong to the NF‐κB/Rel family of proteins. Inactive NF‐κB is present in the cytoplasm complexed with an inhibitory protein, IκB. NF‐κB is activated by a number of incoming signals from the cell surface. Released from IκB inhibition, NF‐κB translocates into the nucleus and binds to the κB motif of the target gene. The NF‐κB activation process can be inhibited by pharmacologic agents at each activation step. Glucocorticoids inhibit NF‐κB by directly associating with NF‐κB or by upregulating IκB expression. Cyclosporin and tacrolimus prevent NF‐κB activation by inhibiting the action of calcineurin, a phosphatase that indirectly induces IκB degradation. Deoxyspergualin inhibits NF‐κB by blocking its nuclear translocation. Aspirin and salicylates inhibit upstream events inducing IκB phosphorylation. Tepoxalin and antioxidants inhibit NF‐κB activation by influencing the redox state of the cell. Further research is required to develop more specific inhibitors to treat diseases mediated by NF‐κB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Schreck, R., Rieber, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,816
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,001
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,752
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
The mechanism of action of cyclosporin A and FK506
Schreiber, S. L., & Crabtree, G. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90111-j · Cited by 2,127
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., & Baltimore, D. (1995) · Nature · doi:10.1038/376167a0 · Cited by 1,825
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Cited by
Milk thistle in liver diseases: past, present, future
Abenavoli, L., Capasso, R., Milic, N., & Capasso, F. (2010) · Phytotherapy Research · doi:10.1002/ptr.3207 · Cited by 599
Shakoor, H., Feehan, J., Al Dhaheri, A. S., Ali, H. I., Platat, C., Ismail, L. C., Apostolopoulos, V., & Stojanovska, L. (2021) · Maturitas · doi:10.1016/j.maturitas.2020.08.003 · Cited by 465
Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors
Haddad, J. J. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(02)00053-0 · Cited by 427
Multiple Molecular Penumbras after Focal Cerebral Ischemia
Sharp, F. R., Lu, A., Tang, Y., & Millhorn, D. E. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200007000-00001 · Cited by 403
TNF ligands and receptors – a matter of life and death
MacEwan, D. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704549 · Cited by 391
Metadata
- Authors
- Lee, J., & Burckart, G. J.
- Venue
- The Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1998-11
- Volume
- 38
- Issue
- 11
- Pages
- 981-993
- ISSN
- 0021-9754 (ISSN-L)
- 0091-2700
- 1552-4604
- OpenAlex
- W1963709111
- Cited by
- 365
- References
- 81
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target. https://app.cochat.ai/papers/10.1177/009127009803801101
- The paper
- Lee, J., & Burckart, G. J. (1998). Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target. The Journal of Clinical Pharmacology. https://doi.org/10.1177/009127009803801101
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.